Homepage Knowledge centers Peptides in the era of biotech

Peptides in the era of biotech

19/03/2024

Article

For more informations about EXPRESSION COSMETIQUE Magazine, please contact: Véronique LOUIS, veronique.louis@expression-cosmetique.fr
Source: Expression Cosmétique N°85 daté Janvier-Février 2024

Name

Job title

Latest news

See all

Expertise / White paper

Polymers in Ophthalmology – A Perfect Match for Vision Innovation

Ocular drug delivery is limited by biological barriers. To overcome these challenges, polymer-based materials are allowing to improve drug retention, penetration, and enabling sustained release. Different polymer types are used across formulations and devices to enhance treatment efficacy and reduce dosing frequency. What you will learn:

Products / Article

Future Ready Corrosion Protection: Designing Calcium Sulfonate Systems for Next Generation Formulations

Corrosion represents a major industrial and economic challenge, costing about $2.5 trillion per year, or 3–4% of the GDP of industrialized countries. Its impact is so significant that around 40% of all new steel produced globally is used simply to replace steel lost to corrosion.
In the context of stricter HSE regulations, more demanding operating conditions, and increasing pressure to improve sustainability, industries need protection systems that go beyond basic coatings. This is why calcium sulfonatebased technologies have become essential: they deliver strong water displacement, stable hydrophobic films, and reliable performance during storage, transport, and interprocess operations

Expertise / Article

Contrast Agents: Market Trends, Technologies and Industrial Challenges

Medical imaging continues to expand steadily, driven by the rise in chronic diseases, the demand for earlier diagnosis, and the emergence of new technologies. At the center of this dynamic are contrast agents, essential for more than half of all CT scans and over 40% of MRI procedures.

The global contrast agents market is projected to reach$7.4 billion by 2026, with an estimated annual growth rate of 6–8%.
Every year, more than 400 million doses are administered worldwide, underscoring the strategic importance of these products for healthcare systems.

Expertise / White paper

Mastering Complexity: Turning a Challenging API Into a Fully Validated GMP Process

WHITE PAPER : Over the past ten years, Seqens has partnered with a rapidly growing European biotech to transform a highly challenging small‑molecule candidate, from an immature laboratory route with low yields and impurity risks, into a fully industrialized, validated GMP process now running at up to 2.5 tons.

Contact